Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries and in the cosmetic sector in Italy. The company offers pharmaceutical products, including powders, soluble, effervescent and chewable granules, filmed and effervescent tablets, fast melting/sublingual tablets, film-coated tablets… Read more
Fine Foods & Pharmaceuticals N.T.M. S.p.A. (9S5) - Total Liabilities
Latest total liabilities as of September 2025: €123.98 Million EUR
Based on the latest financial reports, Fine Foods & Pharmaceuticals N.T.M. S.p.A. (9S5) has total liabilities worth €123.98 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. - Total Liabilities Trend (2021–2024)
This chart illustrates how Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Competitors by Total Liabilities
The table below lists competitors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baiksan
KO:035150
|
Korea | ₩194.88 Billion |
|
Delta Asia International Corporation
TWO:6762
|
Taiwan | NT$1.64 Billion |
|
Ample Electronic Technology Co Ltd
TWO:4760
|
Taiwan | NT$519.41 Million |
|
NoiBai Cargo Terminal Services JSC
VN:NCT
|
Vietnam | ₫259.31 Billion |
|
Chialin Precision Industrial Co Ltd
TWO:3310
|
Taiwan | NT$4.18 Billion |
|
aTyr Pharma, Inc.
NASDAQ:ATYR
|
USA | $26.88 Million |
|
Full House Resorts Inc
NASDAQ:FLL
|
USA | $66.87 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fine Foods & Pharmaceuticals N.T.M. S.p.A. (2021–2024)
The table below shows the annual total liabilities of Fine Foods & Pharmaceuticals N.T.M. S.p.A. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €110.53 Million | -3.54% |
| 2023-12-31 | €114.59 Million | -31.19% |
| 2022-12-31 | €166.53 Million | +7.03% |
| 2021-12-31 | €155.59 Million | -- |